Statements (29)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:drug
prodrug |
gptkbp:approvedBy |
gptkb:FDA
2011 (US) |
gptkbp:ATCCode |
N03AX24
|
gptkbp:brand |
gptkb:Horizant
Regnite |
gptkbp:CASNumber |
1041370-39-7
|
gptkbp:chemicalFormula |
C16H27NO6
|
gptkbp:developedBy |
gptkb:XenoPort
|
gptkbp:eliminationHalfLife |
5-7 hours
|
gptkbp:excretion |
renal
|
https://www.w3.org/2000/01/rdf-schema#label |
gabapentin enacarbil
|
gptkbp:legalStatus |
prescription only
|
gptkbp:marketedAs |
gptkb:Arbor_Pharmaceuticals
GlaxoSmithKline |
gptkbp:metabolism |
hydrolysis
|
gptkbp:prodrugOf |
gptkb:gabapentin
|
gptkbp:routeOfAdministration |
oral
|
gptkbp:sideEffect |
dizziness
fatigue headache drowsiness |
gptkbp:UNII |
6B9H1V8A4V
|
gptkbp:usedFor |
gptkb:restless_legs_syndrome
postherpetic neuralgia |
gptkbp:bfsParent |
gptkb:XenoPort
gptkb:Horizant |
gptkbp:bfsLayer |
7
|